Compared with controls, SCA3 patients exhibit lower levels of thiol protein and activity of antioxidant enzymes, such as SOD and GSH-PX, as well as higher oxidative stress and increased mitochondrial and nuclear DNA damage [29,30,31]. The gene discussed is SOD1; the disease is Spinocerebellar ataxia type 3.